Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab

Cetuximab is a chimeric mouse-human monoclonal antibody biologic used for the treatment of epidermal growth factor receptor-positive colorectal cancer and head and neck cancer. The incidence of severe anaphylaxis after infusion of cetuximab is a rare but fatal complication. Galactose-α-1,3-galactose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hane, Atsuya, Ito, Asami, Ishikura, Ken, Imai, Hiroshi, Okugawa, Yoshinaga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325656/
https://www.ncbi.nlm.nih.gov/pubmed/35903575
http://dx.doi.org/10.7759/cureus.26351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325656/
https://www.ncbi.nlm.nih.gov/pubmed/35903575
http://dx.doi.org/10.7759/cureus.26351

Ejemplares similares